Olivier Loeillot, Chief Executive Officer at REPLIGEN CORP (RGEN), sold 5,535 shares at $178.75 ($1.0M) on 2026-10-05, disclosed to the SEC on 2026-10-06.
Scheduled sale ($1.0M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $178.75 | 1,333 | $238K | 23.0% |
| 2 | $190.00 | 4,202 | $798K | 77.0% |
| Total | $187.29 avg | 5,535 | $1.0M | 100% |
| Filing → |
| RGEN | SELL | 2026-09-08 | $504K | — | Filing → |
| RGEN | SELL | 2026-08-21 | $977K | — | Filing → |
| RGEN | SELL | 2026-04-22 | $536K | — | Filing → |